Hence, pharmacological activation of SIRT1 may be an effective therapeutic strategy for hypertension and hyperlipidemia, and the SIRT1 activator resveratrol further confirmed this hypothesis (45). The gene discussed is SIRT1; the disease is hyperlipidemia.